SEPRACOR
Dr Reddy's Laboratories will infringe on Lunesta's patent: US court of appealThe United States Court of Appeals for the Federal Circuit has ruled that Dr Reddy's Laboratories Ltd will (rpt will) infringe on the paten...- FDA nod for three Glenmark drugsGlenmark Pharmaceuticals said it has received the US health regulator's approval to market three generic products in the American market.
- Glenmark settles patent suit with Sepracor over insomnia drugGlenmark Pharmaceuticals today said it has entered into a settlement agreement with American firm Sepracor, which could pave way for the In...
- Lupin declares litigation settlement with Schering-PloughLupin Ltd has settled all ongoing Hatch-Waxman litigation relating to desloratadine tablets, the generic version of Schering-Plough's Clari...
- Sepracor spanner in Sun Pharma's US planUS-based drug giant Sepracor Inc and the University of Massachusetts have filed a patent infringement suit with the US district court of Ne...
Load More- Lupin declares litigation settlement with Schering-Plough